Details van artikel 134 van 222 gevonden artikelen
Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study
Titel:
Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study
Auteur:
Owonikoko, T.K. Kim, H.R. Govindan, R. Ready, N. Reck, M. Peters, S. Dakhil, S.R. Navarro, A. Rodriguez-Cid, J. Schenker, M. Lee, J.S. Gutierrez, V. Percent, I. Morgensztern, D. Fairchild, J. Baudelet, C. Park, K.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 30 () nr. S2 pagina's ii77
Jaar:
2019
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 134 van 222 gevonden artikelen